US 9938353
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
granted A61KA61K38/57A61P
Quick answer
US patent 9938353 (Compositions, methods and uses for alpha-1 antitrypsin fusion molecules) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/57, A61P, A61P13/08, A61P15/10